Transplantation Market

Transforming Transplantation Market Trends, Growth Insights, and Future Outlook

No comments

According to IMARC Group’s latest research report, titled “Transplantation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028,” the global transplantation market size reached US$ 14.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 26.6 Billion by 2028, exhibiting a growth rate (CAGR) of 9.6% during 2023-2028.

Get Free Sample Copy of Report at – https://www.imarcgroup.com/transplantation-market/requestsample

Transplantation Market Outlook:

Transplantation is a medical procedure that involves the transfer of organs or tissues from one individual to another, in order to replace or repair damaged or diseased organs or tissues. It is done to improve or restore the function of the recipient’s body, allowing them to live a healthier and longer life. It is performed when the recipient’s organ or tissue fails, usually due to illness, injury, or congenital defects. It is majorly performed on the heart, kidneys, liver, lungs, pancreas, skin, bone and corneas. In order for transplantation to be successful, the donor and recipient must be carefully matched to minimize the risk of rejection, in which the recipient’s immune system attacks the transplanted organ or tissue. Immunosuppressive drugs are often used to prevent rejection, although they can have side effects and increase the risk of infections.

Transplantation Market Trends:

Other Post You May Be Interested In

The escalating healthcare expenditure majorly drives the global market. This can be supported by the growing prevalence of chronic diseases and the growing geriatric population. Along with this, the increasing number of organ failures due to acute diseases, severe trauma, drug abuse, sepsis, and other factors, along with lifestyle disorders caused by unhealthy habits, including smoking, alcohol consumption, and physical inactivity, is contributing to the demand for transplantation among the masses. In addition, the growing public awareness of medical advancements and a shortage of organ donors further supporting the market. Moreover, continual technological advancements, such as the introduction of 3D bioprinting, decellularization, and interspecies organogenesis, are creating a positive market outlook. Some of the other factors driving the market include the rapid expansion of tissue banks and continual improvements in healthcare infrastructure.

Key Market Segmentation:

Competitive Landscape with Key Players:

  • 21st Century Medicine
  • AbbVie Inc.
  • Arthrex Inc.
  • Astellas Pharma Inc.
  • BioLife Solutions Inc.
  • CareDx Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • TransMedics Inc.
  • Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)

Product Insights:

  • Tissue Products
  • Immunosuppressive Drugs
  • Preservation Solution

Application Insights:

  • Organ Transplantation
  • Tissue Transplantation

End User Insights:

  • Hospitals
  • Transplantation Centers
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

  • Market Performance 
  • Market Outlook
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

SHARE NOW
Tagged with

Leave a Reply

Your email address will not be published. Required fields are marked *